AAAAAA

   
Results: 1-25 |
Results: 25
Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration
Authors: Arase, Y Ikeda, K Chayama, K Murashima, N Tsubota, A Suzuki, Y Saitoh, S Kobayashi, M Kobayashi, M Suzuki, F Kumada, H
Citation: Y. Arase et al., Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration, HEPATOL RES, 19(1), 2001, pp. 22-30
Incidence of the appearance of the red color sign on esophageal varices and its predictive factors: long-term observations of 359 patients with cirrhosis
Authors: Murashima, N Ikeda, K Kobayashi, M Saitoh, S Chayama, K Tsubota, A Suzuki, Y Suzuki, F Arase, Y Kumada, H
Citation: N. Murashima et al., Incidence of the appearance of the red color sign on esophageal varices and its predictive factors: long-term observations of 359 patients with cirrhosis, J GASTRO, 36(6), 2001, pp. 368-374
Interferon therapy for flare-up of hepatitis B virus infection after emergence of lamivudine-induced YMDD motif mutant
Authors: Someya, T Suzuki, Y Arase, Y Kobayashi, M Suzuki, F Tsubota, A Saitoh, S Chayama, K Murashima, N Ikeda, K Kumada, H
Citation: T. Someya et al., Interferon therapy for flare-up of hepatitis B virus infection after emergence of lamivudine-induced YMDD motif mutant, J GASTRO, 36(2), 2001, pp. 133-136
Schedule-dependent combined sensitivity testing of anti-cancer agents in human gastric carcinoma cell lines
Authors: Murashima, N Gochi, A Kenmotsu, M Hamazaki, K Funaki, M Ohtsuka, S Tanaka, N
Citation: N. Murashima et al., Schedule-dependent combined sensitivity testing of anti-cancer agents in human gastric carcinoma cell lines, J INT MED R, 29(3), 2001, pp. 189-197
Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: A preliminary study
Authors: Tsubota, A Arase, Y Saitoh, S Kobayashi, M Suzuki, Y Suzuki, F Chayama, K Murashima, N Ikeda, K Kobayashi, M Kumada, H
Citation: A. Tsubota et al., Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: A preliminary study, AM J GASTRO, 96(2), 2001, pp. 557-562
Distinction between chronic hepatitis and liver cirrhosis in patients withhepatitis C virus infection. Practical discriminant function using common laboratory data
Authors: Ikeda, K Saitoh, S Kobayashi, M Suzuki, Y Tsubota, A Suzuki, F Arase, Y Murashima, N Chayama, K Kumada, H
Citation: K. Ikeda et al., Distinction between chronic hepatitis and liver cirrhosis in patients withhepatitis C virus infection. Practical discriminant function using common laboratory data, HEPATOL RES, 18(3), 2000, pp. 252-266
Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial course
Authors: Arase, Y Ikeda, K Chayama, K Murashima, N Tsubota, A Suzuki, Y Saitoh, S Kobayashi, M Kobayashi, M Suzuki, F Kumada, H
Citation: Y. Arase et al., Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial course, J GASTRO, 35(8), 2000, pp. 607-612
Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma
Authors: Ikeda, K Saitoh, S Kobayashi, M Suzuki, Y Suzuki, F Tsubota, A Arase, Y Chayama, K Murashima, N Kumada, H
Citation: K. Ikeda et al., Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma, J GASTRO, 35(5), 2000, pp. 353-360
Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C
Authors: Arase, Y Ikeda, K Chayama, K Murashima, N Tsubota, A Suzuki, Y Saitoh, S Kobayashi, M Kobayashi, M Suzuki, F Kumada, H
Citation: Y. Arase et al., Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C, J GASTRO, 35(3), 2000, pp. 221-225
Progressive and sufficient decrease of hepatitis B core antibody can predict the disappearance of hepatitis B virus DNA in Japanese patients with hepatitis B surface antigen clearance
Authors: Kobayashi, M Chayama, K Arase, Y Tsubota, A Saitoh, S Suzuki, Y Kobayashi, M Murashima, N Ikeda, K Hagiwara, M Hashimoto, R Nakagawa, M Matsuda, M Kumada, H
Citation: M. Kobayashi et al., Progressive and sufficient decrease of hepatitis B core antibody can predict the disappearance of hepatitis B virus DNA in Japanese patients with hepatitis B surface antigen clearance, J GASTRO, 35(10), 2000, pp. 753-757
Association of amino acid sequence in the PKR-eIF2 phosphorylation homology domain and response to interferon therapy
Authors: Chayama, K Suzuki, F Tsubota, A Kobayashi, M Arase, Y Saitoh, S Suzuki, Y Murashima, N Ikeda, K Takahashi, N Kinoshita, M Kumada, H
Citation: K. Chayama et al., Association of amino acid sequence in the PKR-eIF2 phosphorylation homology domain and response to interferon therapy, HEPATOLOGY, 32(5), 2000, pp. 1138-1144
Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor - A prospective randomized study of hepatitis C virus-related liver cancer
Authors: Ikeda, K Arase, Y Saitoh, S Kobayashi, M Suzuki, Y Suzuki, F Tsubota, A Chayama, K Murashima, N Kumada, H
Citation: K. Ikeda et al., Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor - A prospective randomized study of hepatitis C virus-related liver cancer, HEPATOLOGY, 32(2), 2000, pp. 228-232
Helicobacter pylori infection in renal transplant recipients
Authors: Fujiwara, T Hamazaki, K Ikeda, Y Murashima, N Matsumoto, T Akura, Y Nishisita, C Umekawa, Y
Citation: T. Fujiwara et al., Helicobacter pylori infection in renal transplant recipients, TRANSPLAN P, 32(7), 2000, pp. 1976
Selective writing of sub-mu m(2) domain in spin valve strip with current coincident scheme
Authors: Matsuyama, K Murashima, N Higashidani, M Nozaki, Y
Citation: K. Matsuyama et al., Selective writing of sub-mu m(2) domain in spin valve strip with current coincident scheme, IEEE MAGNET, 36(5), 2000, pp. 2767-2769
Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis
Authors: Kobayashi, M Ikeda, K Saitoh, S Suzuki, F Tsubota, A Suzuki, Y Arase, Y Murashima, N Chayama, K Kumada, H
Citation: M. Kobayashi et al., Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis, CANCER, 88(11), 2000, pp. 2471-2477
Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients
Authors: Tsubota, A Kumada, H Arase, Y Chayama, K Saitoh, S Ikeda, K Kobayashi, M Suzuki, Y Murashima, N
Citation: A. Tsubota et al., Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients, EUR J GASTR, 11(10), 1999, pp. 1077-1083
Clinical and virological features of chronic hepatitis C carriers with normal alanine aminotransferase levels despite positive serum HCV-RNA after interferon therapy
Authors: Arase, Y Ikeda, K Chayama, K Murashima, N Tsubota, A Nakamura, I Suzuki, Y Saitoh, S Kobayashi, M Kobayashi, M Kobayashi, M Kumada, H
Citation: Y. Arase et al., Clinical and virological features of chronic hepatitis C carriers with normal alanine aminotransferase levels despite positive serum HCV-RNA after interferon therapy, J GASTRO, 34(5), 1999, pp. 594-599
Efficacy and changes of the nonstructural 5A gene by prolonged interferon therapy for patients with hepatitis C virus genotype 1b and a high level ofserum HCV-RNA
Authors: Arase, Y Ikeda, K Chayama, K Murashima, N Tsubota, A Suzuki, Y Saitoh, S Kobayashi, H Kobayashi, M Kobayashi, M Kumada, H
Citation: Y. Arase et al., Efficacy and changes of the nonstructural 5A gene by prolonged interferon therapy for patients with hepatitis C virus genotype 1b and a high level ofserum HCV-RNA, INTERN MED, 38(6), 1999, pp. 461-466
Prevalence of TT virus before and after blood transfusion in patients withchronic liver disease treated surgically for hepatocellular carcinoma
Authors: Kobayashi, M Chayama, K Arase, Y Kobayashi, M Tsubota, A Suzuki, Y Koida, I Saitoh, S Murashima, N Ikeda, K Koike, H Hashimoto, M Kobayashi, M Kumada, H
Citation: M. Kobayashi et al., Prevalence of TT virus before and after blood transfusion in patients withchronic liver disease treated surgically for hepatocellular carcinoma, J GASTR HEP, 14(4), 1999, pp. 358-363
Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis
Authors: Ikeda, K Saitoh, S Arase, Y Chayama, K Suzuki, Y Kobayashi, M Tsubota, A Kobayashi, M Nakamura, I Murashima, N Kumada, H Kawanishi, M
Citation: K. Ikeda et al., Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis, HEPATOLOGY, 29(4), 1999, pp. 1124-1130
Chronic liver disease in the extremely elderly of 80 years or more: clinical characteristics, prognosis and patient survival analysis
Authors: Hoshida, Y Ikeda, K Kobayashi, M Suzuki, Y Tsubota, A Saitoh, S Arase, Y Kobayashi, M Murashima, N Chayama, K Kumada, H
Citation: Y. Hoshida et al., Chronic liver disease in the extremely elderly of 80 years or more: clinical characteristics, prognosis and patient survival analysis, J HEPATOL, 31(5), 1999, pp. 860-866
Susceptibility of TT virus to interferon therapy
Authors: Chayama, K Kobayashi, M Tsubota, A Kobayashi, M Arase, Y Suzuki, Y Saitoh, S Murashima, N Ikeda, K Okamoto, K Hashimoto, M Matsuda, M Koike, H Kobayashi, M Kumada, H
Citation: K. Chayama et al., Susceptibility of TT virus to interferon therapy, J GEN VIROL, 80, 1999, pp. 631-634
Time course of histological changes in patients with a sustained biochemical and virological response to corticosteroid withdrawal therapy for chronic hepatitis B
Authors: Arase, Y Ikeda, K Murashima, N Chayama, K Tsubota, A Koida, I Suzuki, Y Saitoh, S Kobayashi, M Kobayashi, M Kobayashi, M Kumada, H
Citation: Y. Arase et al., Time course of histological changes in patients with a sustained biochemical and virological response to corticosteroid withdrawal therapy for chronic hepatitis B, AM J GASTRO, 94(11), 1999, pp. 3304-3309
Vaginal variceal hemorrhage in a patient with primary biliary cirrhosis: Acase successfully treated by balloon-occluded retrograde transvenous obliteration
Authors: Hoshida, Y Saitoh, S Murashima, N Ogawa, A Arase, Y Kobayashi, M Suzuki, Y Tsubota, A Chayama, K Ikeda, K Kumada, H
Citation: Y. Hoshida et al., Vaginal variceal hemorrhage in a patient with primary biliary cirrhosis: Acase successfully treated by balloon-occluded retrograde transvenous obliteration, AM J GASTRO, 94(10), 1999, pp. 3081-3083
Relationship of angiographic finding with neovascular structure detected by immunohistochemical staining of alpha-smooth muscle actin in small hepatocellular carcinoma
Authors: Ikeda, K Saitoh, S Suzuki, Y Kobayashi, M Tsubota, A Koida, I Kobayashi, M Arase, Y Chayama, K Murashima, N Kumada, H
Citation: K. Ikeda et al., Relationship of angiographic finding with neovascular structure detected by immunohistochemical staining of alpha-smooth muscle actin in small hepatocellular carcinoma, J GASTR HEP, 13(12), 1998, pp. 1266-1273
Risultati: 1-25 |